iiinova — where your digital self keeps evolving

eickelbergmd.bsky.social

@eickelbergmd.bsky.social

33 followers 14 following 1 posts

Posts Replies Media

eickelbergmd.bsky.social @eickelbergmd.bsky.social · 10/04/2025

Thanks for inviting us to @yalepccsm.bsky.social 🙏. Wonderful to meet you and so many friends!

030

Reposted by @eickelbergmd.bsky.social

The American Society for Clinical Investigation @the-asci.org · 08/04/2025

Our current issue's special collection of Physician-Scientist Development articles includes an editorial by Editor in chief @eickelbergmd.bsky.social & is paired with a cover collage of children's drawings illustrating what a 'physician-scientist' means to them: buff.ly/mWGTpMV

032

Reposted by @eickelbergmd.bsky.social

JCI insight @insight.jci.org · 06/03/2025

@markesnyder.bsky.social et al. flip the script on our understanding of infection and rejection after transplantation– they show that systemic NKG2D blockade can impair airway-associated Tissue resident memory T cell accumulation and reduce CLAD severity: buff.ly/61mpbwk

022

Reposted by @eickelbergmd.bsky.social

Eric Topol @erictopol.bsky.social · 06/03/2025

Just published @science.org A basis—lung inflammation—for #LongCovid (PASC) in the experimental model, and a potential therapy [driven by alveolar macrophages and loss of their peroxisomes (Figure)] www.science.org/doi/10.1126/... www.science.org/doi/10.1126/...

graphic depicts that lung alveolar macrophages loss of peroxisome drives the process

15369121

Reposted by @eickelbergmd.bsky.social

JCI insight @insight.jci.org · 04/03/2025

Emanual Maverakis et al. use single-cell and bulk RNA-seq and immunohistochemistry to characterize necrobiosis and identified SPP1 and CCL5 as novel therapeutic targets for NL and NXG, rare diseases without a highly effective therapy: buff.ly/7htsyLe

022

Reposted by @eickelbergmd.bsky.social

Alt National Park Service @altnps.bsky.social · 14/12/2024

267120941112